| Before propensity Score Matching | After propensity Score Matching | ||||
---|---|---|---|---|---|---|
CT group | Control group | P-value | CT group | Control group | P-value | |
Number of cycles | 731 | 1949 | Â | 670 | 670 | Â |
Still birth, n‰ | 0 (0) | 1 (1.13) | 0.579 | 0 (0) | 0 (0) |  |
Gestational age (weeks) | 37.87 ± 2.23 | 38.34 ± 1.74 | 0.001 | 37.86 ± 2.24 | 38.49 ± 1.46 | 0.173 |
Gender a | Â | Â | 0.109 | Â | Â | 0.084 |
male, n(%) | 154 (56.62) | 452 (51.02) | 144 (56.69) | 122 (49.00) | ||
female, n(%) | 118 (43.38) | 433 (48.87) | 110 (43.31) | 127 (51.00) | ||
Weight (g) b | 3273.24 ± 1701.92 | 3229.60 ± 503.22 | 0.267 | 3276.02 ± 1752.75 | 3241.89 ± 429.292 | 0.589 |
Maternal obstetric complications c, n(%) | 26 (9.89) | 72 (8.52) | 0.496 | 24 (9.80) | 16 (6.69) | 0.215 |
Neonatal birth defect d, n(%) | 2 (0.74) | 7 (0.79) | 0.927 | 2 (0.79) | 2 (0.80) | 0.984 |